Source: INOVIQ
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • INOVIQ (IIQ) receives an Australian patent for its SubB2M technology, which the company now holds exclusive worldwide rights to the IP for its diagnostic applications
  • The company was awarded the Australian Patent number 2017358401 entitled “Subtilase cytotoxin B subunit mutant”, issued to Griffith University and the University of Adelaide
  • The patent is due to expire on November 9, 2037
  • The granting of the Australian patent is another important step in the company’s path to commercialisation for its SubB2M-based tests and follows other recent key milestones
  • IIQ shares are up 6.14 per cent, trading at 60.5 cents

INOVIQ (IIQ) has been granted an Australian patent for its SubB2M technology and now holds exclusive worldwide rights to the SubB2M intellectual property for diagnostic applications.

The company was awarded the Australian Patent number 2017358401 entitled “Subtilase cytotoxin B subunit mutant”, issued by IP Australia to Griffith University and the University of Adelaide.

The patent is due to expire on November 9, 2037 and claims modified SubB proteins, capable of binding N-glycolylneuraminic acid (Neu5Gc) and variants and fragments thereof, such as SubB2M.

“This patent enforces intellectual property protection in Australia for INOVIQ’s SubB2M-based diagnostics pipeline for monitoring of breast and ovarian cancers,” CEO Dr Leearne Hinch said.

Dr Hinch said this is also the first patent granted for the SubB2M technology and marks a key step in INOVIQ’s path to commercialising its SubB2M-based tests.

The patent also follows other key milestones including the signing of a master services agreement with ResearchDX and a master manufacturing agreement with MP Biomedicals.

The SubB2M diagnostics pipeline is now undergoing further feasibility testing, development, and validation at US-based contract diagnostic organisation, ResearchDx.

IIQ shares were up 6.14 per cent, trading at 60.5 cents at 2:06 pm AEST.

iiq by the numbers
More From The Market Online

Vulcan Energy Resources commences civil construction works at LEP site in Germany

Vulcan Energy Resources has commenced civil construction works for its commercial lithium extraction plant (LEP), part…

Southern Cross Electrical Engineering lands over $300m in data centre and buildings awards

Southern Cross Electrical Engineering subsidiaries have been awarded a range of projects totalling over $300 million.

TruScreen continues global growth with product registration in Kenya

TruScreen Group has received product registration in the Republic of Kenya, a priority market for cervical…
The Market Online Video

Market Open: A cautious start as Wall Street tech stocks retreat

Australian shares are expected to open relatively flat on Monday after another mixed session on Wall Street, where renewed selling in technology stocks